Status | Study |
RECRUITING |
Study Name: Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial Pneumonia Condition: Pneumonia, Bacterial Date: 2023-02-14 Interventions: CAL02 consists of a mixture of 2 liposomes and is a non-biological bacterial virulence neutralizer. |
Recruiting |
Study Name: Cx611-0204 SEPCELL Study Condition: Bacterial Pneumonia Date: 2017-05-09 Interventions: Drug: Cx611 or Placebo Two intravenous infusions, one on day 1 and another one on day 3 |
Recruiting |
Study Name: Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia Condition: Community Acquired Bacterial Pneumonia Date: 2016-01-27 Interventions: Drug: Delafloxacin Antibacteri |
Recruiting |
Study Name: Safety and Efficacy of Solithromycin in Adolescents and Children With Community-acquired Bacterial Pneumonia Condition: Community-acquired Bacterial Pneumonia Date: 2015-11-10 Interventions: Drug: Solithromycin Other Name |
Recruiting |
Study Name: Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Condition: Bacterial Pneumonia Date: 2015-07-07 Interventions: Drug: Imipenem Imipenem 500 mg |
Recruiting |
Study Name: A Study to Assess the Pharmacokinetic Profile, the Safety, and the Tolerability of ME1100 Inhalation Solution in Patients With Mechanically Ventilated Bacterial Pneumonia Condition: Pneumonia, Bacterial Date: 2015-05-28 Interventions: Drug: ME1100 inhalation solution |
Withdrawn |
Study Name: Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization Condition: Pneumonia, Bacterial Date: 2014-08-14 Interventions: Drug: Amikacin Fosfomycin Inhalation Solution |
Completed |
Study Name: Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia Condition: Pneumonia, Bacterial Date: 2013-10-22 Interventions: Drug: Amikacin fosfomycin inhalation solution |
Completed |
Study Name: Efficacy and Safety Study of Intravenous to Oral Solithromycin (CEM-101) Compared to Intravenous to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia Condition: Community-acquired Bacterial Pneumonia Date: 2013-10-21 Interventions: Drug: Solithromycin Other Name |
Completed |
Study Name: Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Condition: Pneumonia, Bacterial Date: 2013-02-25 Interventions: Drug: Amikacin Inhalation Solution (BAY41-6551) |